ArticleScientific reports2024

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma.

Moxuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.